On Sunday, July 7, 2024, we exhibited at the Institute for Predictable Osseointegration in Implantology (IPOI), a non-profit organization (NPO) event held in Fukuoka City.
Read more
Mediplus Pharma, Inc. presented the safety and efficacy of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), in formulations for atopic dermatitis at the 123rd Annual Meeting of the Japanese Dermatological Association. The conference was held from June 6 to June 9, 2024, at the Kyoto International Conference Center.
For more details on the press release, please visit here.
https://prtimes.jp/main/html/rd/p/000000015.000079724.html
Mediplus Pharma, Inc. (CEO: Kenji Ito, HQ: Shibuya, Tokyo) presented on the multifunctionality and application of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), as biomaterials at the 12th World Biomaterials Congress (WBC), held over six days from May 26 to 31, 2024, in Daegu, South Korea.
For more details on the press release, please visit here.
https://prtimes.jp/main/html/rd/p/000000013.000079724.html
We are pleased to announce our participation in the 16th Academic Conference of the Non-Profit Organization (NPO) Institute for Predictable Osseointegration in Implantology, which will be held on Sunday, July 7, 2024, in Fukuoka City.
We aim to introduce our unique ingredient , ozonized glycerin, which is expected to have beneficial effects in dental medicine, particularly in the surgical field. This event will be an opportunity for dental professionals, especially those active in the surgical domain, to learn about our product.
At our exhibition booth, attendees will be able to experience ozonized glycerin and deepen their understanding through explanations from the developers.
Aggravating factor is a cause that makes a medical condition or symptom worse.Also called exacerbating factors. They range from specific allergens that worsen allergic reactions, to lifestyle habits such as smoking and alcohol consumption that exacerbate the disease, drug interactions and psychological stress.
Tyrosinase is the enzyme responsible for the melanogenic reaction from tyrosine. It is also known by another name as monophenol monooxygenase. When the skin is exposed to UV light or other stimuli, a signal transmitter flows from keratinocytes to melanocytes, activating tyrosinase, which catalyzes the aforementioned synthetic reaction.
A catalyst is a substance that increases the rate of reaction of a particular chemical reaction. This action occurs by adsorption of molecules on the surface of the catalyst.
A polypeptide is a component of a protein, a substance made up of a large number of amino acids bonded together.
Melanin is the pigment that determines the color of skin, hair, and eyes. The ratio of melanin pigment makes a difference in these colors. Melanin protects skin and hair from UV damage. Although it is often seen negatively as a cause of sunburn and dark spots, melanin is produced to protect our bodies by darkening the skin and reducing UV damage.
Tranexamic acid is a drug used as an antiplasmin agent and has hemostatic properties. It promotes blood coagulation and inhibits bleeding. It is also used in skin care products because of its inhibitory effects on melanin production and inflammation.